IgA nephropathy: 30 years on

Journal of Internal Medicine

Volumn 242, Issue 5, 1997, Pages 349-353

  Pettersson, E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

IgA nephropathy

Indexed keywords

GLYCOPROTEIN GP 39; HLA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 6; TETANUS TOXOID;

BLOOD PRESSURE REGULATION; DISEASE COURSE; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW;

EID: 0030859858     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00194.x     Document Type: Review

References (56)

1. Berger J, Hinglais N. Les dépots intracapillaires d'IgA-IgG. J Urol Nephrol 1968; 74: 644-5 (in Danish).
2. Remusai G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15.
3. Clarkson A, Seymour A, Thompson A, Haynes W, Chan Y-L, Jackson B. IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 1977; 8: 459-71.
4. Rambausek M, Rauterberg E, Waldherr R, Demaine A, Krupp G, Ritz E. Evaluation of IgA glomerulonephritis. Relation to morphology, immunogenetics and blood pressure. Semin Nephrol 1987; 7: 371-7.
5. Tiebosch A, Wollers J, Frederik P, van der Weil T, Zeppenfeldt E, Vriesman B. Epidemiology of idiopathic glomerular disease: A prospective study. Kidney Int 1987; 32: 112-16.
6. Simon P, Rameé M-P, Autuly V, Laruelle E, Charasse C, Cam G, Ang K. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 1994; 46: 1192-8.
7. Sinniah R, Pwee HS, Kim CH. Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination. Clin Nephrol 1976; 5: 216-28.
8. Chen B, Ooi BS, Tan K, Lim C. Comparative studies of asymptomatic proteinuria and hematuria. Arch Intern Med 1974; 134: 901-5.
9. von Bonsdorff M, Koskenvuo K, Salmi H, Pasternack A. Prevalence and causes of proteinuria in 20-year-old Finnish men. Scand J Urol Nephrol 1981; 15: 285-90.
10. Pettersson E, von Bonsdorff M, Törnroth T, Lindholm H, Nephritis among young Finnish men. Clin Neprol 1984; 22: 217-22.
11. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-47.
12. Sinniah R. Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 1983; 36: 276-9.
13. Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in a nonselected autopsy series. Nephrol Dial Transplant 1989; 4: 943-6.
14. Pettersson E. Epidemiology of nephritis. Scand J Urol Nephrol 1992; 26: 1-9.
15. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 245: 709-27.
16. Rekola S. Prognosis in IgA nephropathy. Dissertation. Karolinska Institute, Stockholm, Sweden 1991.
17. D'Amico G, Ragni A, Gandini E, Fellin G. Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol 1993; 104: 6-13.
18. Clarkson AR, Woodroffe AJ, Bannister KM, Odum J, Thomas A. Therapy in IgA nephropathy. Contrib Nephrol 1993; 104: 189-97.
19. Waldo F, Wyatt R, Kelly D, Herrera G, Benfield M, Kohaut E. Treatment of IgA nephropathy in children: efficacy of alternate day oral prednisone. Pediatr Nephrol 1993; 7: 529-32.
20. Donadio J, Bergstralh E, Offord K, Spencer D, Holley K. A controlled trial of fish oil in IgA nephropathy. NEJM 1994; 331: 1194-9.
21. Pettersson E, Rekola S, Berglund L, Sundqvist K, Angelin B, Diczfalusy U, et al. Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double blind, randomized study. Clin Nephrol 1994; 41: 183-90.
22. Dillon JJ. Fish oil for IgA nephropathy: efficacy and interstudy variability. JASN 1996; 7: 1332 (abstract).
23. Border W, Noble A, Yamamoto T, Tomooka S, Kagami S. Antagonists of transforming growth factor β: a novel renal approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 1992; 41: 566-70.
24. Peterson JC, Adler S, Burkart JM, Greene T, Hebert L, Hunsicker L, et al. Blood pressure control, proteinuria, and the progression of renal disease. Ann Int Med 1995; 123: 754-62.
25. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980; 66: 1432-6.
26. Tomino Y, Endoh M, Nomoto Y, Sakai H. Immunoglobulin A1 in IgA nephropathy. N Engl J Med 1981; 305: 1159-60.
27. Valentijn RM, Radl J, Haaijman JJ, Vermeer B, Weening J, Kauffmann R, et al. Circulating and mesangial secretory component-binding IgA1 in primary IgA nephropathy. Kidney Int 1984; 26: 760-66.
28. Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-16.
29. Yoshida K, Suzuki J, Suzuki S, Kume K, Mutoh S, Kato K, Suzuki H. Experimental IgA nephropathy induced by coxsackie B4 virus in mice. Lab Invest 1997; 17: 81-8.
30. van den Wall Bake AWL, Daha M, Radl J, Haaijman J, van der Ark A, Valentijn R, van Es L. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 1988; 72: 321-5.
31. Crowley-Nowich PA, Bull R, van den Wall Bake AWL, Kulhavy L, Julian B, Jackson S. Immunological studies of IgA nephropathy in blacks reveal elevations of serum IgA2 as well as IgA1. Nephrol Dial Transplant 1994; 9: 1324-9.
32. van den Wall Bake AWL, Daha M, Haaijman JJ, Radl J, van der Ark A, van Es L. Elevated production of polymeric and monomeric IgA1 by the bone marrow in patients with IgA nephropathy. Kidney Int 1989; 35: 1400-1404.
33. Feehally J, Beatty TJ, Brenchley P, Coupes B, Mallick N, Postlethwaite R. Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 1986; 30: 924-31.
34. Jones C, Mermelstein N, Kincaid-Smith P, Powell H, Roberton D. Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay. Clin Exp Immunol 1988; 72: 344-9.
35. Layward L, Allen A, Harper S, Hattersley J, Feehally J. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy. Clin Nephrol 1993; 40: 131-6.
36. Layward L, Finnemore A-M, Allen AC, Harper S, Feehally J. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol 1993; 69: 306-13.
37. De Fijter JW, Eijgenraam JW, Braam CA, Holmgren J, Daha M, van Es L, van den Wall Bake AWL. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-61.
38. Leinikki PO, Mustonen M, Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin Exp Immunol 1987; 68: 33-8.
39. Van den Wall Bake AWL, Beyer WEP, Evers-Schouten JH, Hermans J, Daga M, Masurel N, van Es L. Humoral immune response to influenza vaccination in patients with primary IgA nephropathy. An analysis of isotype distribution and size of the influenza specific antibodies. J Clin Invest 1989; 84: 1070-75.
40. Horii Y, Iwano M, Hirata E, Shikii H, Fuji Y, Dohi K, Ishikawa H. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 1993; S39: 71-5.
41. Sakai H, Miyazaki M, Endoch M, Nomoto Y. Increase of IgA-specific switch T-cells in patients with IgA nephropathy. Clin Exp Immunol 1989; 78: 378-82.
42. Lai KN. The cellular immunity and nature of IgA molecules in IgA nephropathy. Contrib Nephrol 1993; 104: 99-111.
43. Baskin B, Pettersson E, Rekola S, Smith C, Islam K. Studies of the molecular basis of IgA production, subclass regulation and class-switch recombination in IgA nephropathy patients. Clin Exp Immunol 1996; 106: 509-17.
44. Levy M. Multiplex families in IgA nephropathy. Contrib Nephrol 1993; 104: 46-53.
45. Sakai H. Cellular immunoregulatory aspects of IgA nephropathy. Am J Kidney Dis 1988; 12: 430-32.
46. Egido J, Blasco R, Sancho J, Lozano L, Gutierrez-Millet V. Immunological studies in a familial IGA nephropathy. Clin Exp Immunol 1983; 54: 532-8.
47. Waldo FB, Beischel L, West CD. IgA synthesis by lymphocytes from patients with IgA nephropathy and their relatives. Kidney Int 1986; 29: 1229-33.
48. Nomoto Y, Sakai H, Arimori S. Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am J Clin Pathol 1979; 71: 158-60.
49. Berthoux FC, Alamartine E, Pommier G, Lepetit J-C. HLA and IgA nephritis revisited 10 years later: HLA-B35 antigen as a prognostic factor. N Engl J Med 1988; 319: 1609-10.
50. Fauchet R, Pogamp PI, Genetet B, Chevet D, Mgueguen Simon P et al. HLA-DR4 antigen and IgA nephropathy. Tissue Antigens 1980; 16: 405-10.
51. Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajiama T. Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 1982; 22: 377-82.
52. Moore RH, Hitman GA, Lucas EY, Richards N, Venning M, Papiha S et al. HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int 1990; 37: 991-5.
53. Li PKT, Burns AP, So A, Pusey C, Feehally J, Rees A. The DQW7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians. Kidney Int 1991; 39: 961-5.
54. Béné M-C, Canton P, Amiel C, May T, Faure G. Absence of mesangial IgA in AIDS. A postmortem study. Nephron 1991; 58: 240-41.
55. Allen AC. Abnormal glycosylation of IgA. Is it related to the pathogenesis of IgA nephropathy? Nephrol Dial Transplant 1995; 10: 1121-4.
56. Mc Coy RC, Abramowsky CR, Tischer CC. IgA nephropathy. Am J Pathol 1974; 76: 123-44.